State Street Corp Vertex Pharmaceuticals Inc Transaction History

State Street Corp

$2.36 Trillion
Q1 2025

A detailed history of State Street Corp transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, State Street Corp holds 11,788,657 shares of VRTX stock, worth $5.54 Billion. This represents 0.24% of its overall portfolio holdings.

Number of Shares

11,788,657

Previous 11,979,405 1.59%

Holding current value

$5.54 Billion

Previous $4.82 Billion 18.48%

% of portfolio

0.24%

Previous 0.2%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	SELL	$402.49 - $513.76 $76.8 Million - $98 Million	-190,748 Reduced 1.59%	11,788,657 $5.72 Billion
Q4 2024 Feb 14, 2025	BUY	$396.64 - $516.74 $64.7 Million - $84.3 Million	163,156 Added 1.38%	11,979,405 $4.82 Billion
Q3 2024 Nov 14, 2024	BUY	$460.0 - $505.78 $41.5 Million - $45.6 Million	90,173 Added 0.77%	11,816,249 $5.5 Billion
Q2 2024 Aug 14, 2024	SELL	$392.81 - $485.53 $110 Million - $136 Million	-280,407 Reduced 2.34%	11,726,076 $5.5 Billion
Q1 2024 May 15, 2024	SELL	$407.69 - $446.08 $31.5 Million - $34.5 Million	-77,335 Reduced 0.64%	12,006,483 $5.02 Billion
Q4 2023 Feb 14, 2024	BUY	$343.0 - $410.68 $15.2 Million - $18.2 Million	44,272 Added 0.37%	12,083,818 $4.92 Billion
Q3 2023 Nov 14, 2023	SELL	$338.18 - $362.46 $98.8 Million - $106 Million	-292,047 Reduced 2.37%	12,039,546 $4.19 Billion
Q2 2023 Aug 14, 2023	BUY	$314.42 - $351.91 $39 Million - $43.7 Million	124,141 Added 1.02%	12,331,593 $4.34 Billion
Q1 2023 May 15, 2023	SELL	$283.23 - $323.1 $46.2 Million - $52.7 Million	-162,978 Reduced 1.32%	12,207,452 $3.85 Billion
Q4 2022 Feb 14, 2023	BUY	$285.76 - $321.48 $21.6 Million - $24.3 Million	75,639 Added 0.62%	12,370,430 $3.57 Billion
Q3 2022 Nov 15, 2022	BUY	$273.83 - $305.53 $8.42 Million - $9.39 Million	30,742 Added 0.25%	12,294,791 $3.56 Billion
Q2 2022 Aug 15, 2022	BUY	$234.96 - $292.55 $49.6 Million - $61.8 Million	211,286 Added 1.75%	12,264,049 $3.46 Billion
Q1 2022 May 16, 2022	SELL	$221.42 - $260.97 $67.3 Million - $79.4 Million	-304,152 Reduced 2.46%	12,052,763 $3.15 Billion
Q4 2021 Feb 14, 2022	BUY	$177.01 - $223.45 $5.93 Million - $7.49 Million	33,499 Added 0.27%	12,356,915 $2.71 Billion
Q3 2021 Nov 15, 2021	BUY	$181.39 - $202.99 $112 Million - $125 Million	617,593 Added 5.28%	12,323,416 $2.24 Billion
Q2 2021 Aug 16, 2021	BUY	$187.49 - $221.1 $99.5 Million - $117 Million	530,785 Added 4.75%	11,705,823 $2.36 Billion
Q1 2021 May 17, 2021	SELL	$207.02 - $241.31 $54 Million - $63 Million	-261,026 Reduced 2.28%	11,175,038 $2.4 Billion
Q4 2020 Feb 16, 2021	BUY	$207.01 - $276.09 $15.3 Million - $20.5 Million	74,118 Added 0.65%	11,436,064 $2.7 Billion
Q3 2020 Nov 10, 2020	SELL	$255.65 - $303.1 $78.3 Million - $92.8 Million	-306,299 Reduced 2.63%	11,361,946 $3.09 Billion
Q2 2020 Aug 14, 2020	BUY	$225.48 - $295.8 $49.4 Million - $64.8 Million	219,002 Added 1.91%	11,668,245 $3.39 Billion
Q1 2020 May 11, 2020	BUY	$199.77 - $247.81 $2.29 Billion - $2.84 Billion	11,449,243 New	11,449,243 $2.72 Billion

Others Institutions Holding VRTX

# of Institutions

1,828

Shares Held

231M

Call Options Held

1.38M

Put Options Held

1.08M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $121B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Account

State Street Corp Vertex Pharmaceuticals Inc Transaction History